Junne Kamihara1, Jaclyn Schienda1, Rose B McGee2

  • 1Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.

概括

遗传性视网膜母细胞瘤 (RB) 影响了45%的被诊断为RB的儿童,增加了眼内和随后恶性瘤 (SMN) 的终身风险. 本报告更新了识别遗传性RB和管理对眼部和非眼部瘤的监测策略.